OncLive | Managing mTOR Inhibitor Side Effects in Breast Cancer OncLive One facet of the discussion, entitled “Metastatic Breast Cancer Treatment Challenges,” featured managing the side effects associated with mTOR inhibitors. ... This randomized, international, phase III trial compared everolimus and exemestane with ... |
